Measuring the Wrong Parameters—JCOG0802: An Interview With Michael Lanuti

In this fascinating interview, CTSNet Editor-in-Chief Joel Dunning spoke with Dr. Michael Lanuti, Director of Thoracic Oncology in the Division of Thoracic Surgery at Massachusetts General Hospital and an Associate Professor at Harvard Medical School, and thoracic surgeon and CTSNet Senior Editor Leanne Ashrafian about Dr. Lanuti’s thoughts on the JCOG0802 trial and how he believes the wrong parameters were measured.  

They discussed local recurrence rates, pulmonary function, and the subtypes of adenocarcinoma. Additionally, they explored how to apply these results to future patients, central and peripheral lesions, and other randomized trials.  

They also covered the five-year results of the JCOG0802 trial and future studies and the implications for future studies, focusing on the parameters that should be considered. Furthermore, they addressed pulmonary function tests and wedge resection. 

Disclaimer

The information and views presented on CTSNet.org represent the views of the authors and contributors of the material and not of CTSNet. Please review our full disclaimer page here.